Tirzepatide - Research Grade

10 mg

$95.00

Tirzepatide

Informative Description: Tirzepatide is a synthetic peptide engineered as a dual hormone receptor agonist (co-agonist). It combines within a single structure the action of two natural incretins in the body: glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1), allowing for a profoundly integrated metabolic modulation.
Peptide Function:
Synergistic Dual Agonism: Simultaneously activates both GIP and GLP-1 receptors, achieving a significantly greater impact on glucose control and lipid metabolism than single selective agonists.
Insulin & Glucagon Optimization: Stimulates insulin secretion in a strictly glucose-dependent manner and regulates glucagon release to maintain glycemic stability.
Gastric Pacing & Satiety Control: Delays gastric emptying and acts directly on appetite control centers in the brain to induce prolonged satiety.
Primary Uses (Research Applications):
Weight Loss & Body Composition Studies: Widely researched in modern medical science for its high efficacy in drastically reducing fat mass and managing obesity.
Metabolic Reversal Research: Utilized in laboratory protocols to analyze improvements in peripheral insulin sensitivity and type 2 diabetes management.
Cardiovascular & Hepatic Protection: Evaluated in emerging scientific models for its protective effects on the cardiovascular system and its ability to decrease fat accumulation in the liver.